Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1739_Библиотеки_им_академика_М_И_Перельмана.pdf
164
A Simple Introduction to Organ Transplant
Dr Gopi Ayyaswamy
Basic Metabolic Panel:
• Glycemic status through fasting, postprandial, and glycated hemoglobin
(HbA1c)
• Lipid prole evaluation
• Serum Electrolyte concentrations,
• Pertinent analysis of other critical serum analyses as indicated.
Renal function tests (RFT): RFT constitutes a pivotal cluster of diagnostic
evaluations tailored to discern the ability of renal physiology. This array of
tests holds paramount signicance in deciphering the dynamic interplay
within the renal system and aids in characterizing its functional integrity.
Among the core parameters encompassed within RFTs are given as follows.
Serum creatinine and blood urea nitrogen (BUN): These analyses,
emanating from nitrogenous waste metabolism, serve as keystone
indicators of renal excretory function. Elevated levels of serum creatinine
and BUN reect deviations in glomerular ltration and tubular secretion,
delineating impairments in kidney function and the excretory capacity of
the nephrons.
Estimated glomerular filtration rate (eGFR): This derivative metric,
hinging upon serum creatinine levels, affords an approtximated gauge of
the overall glomerular ltration capacity. eGFR presents itself as a concise
and clinically practical proxy for discerning the global kidney function,
with diminished values implying a decreased ltration rate and potential
renal insufciency.
The amalgamation of these assessments forms the basics of RFTs,
furnishing clinicians with a comprehensive understanding of renal
dynamics. The judicious synthesis of these results within the patient’s
clinical scenario is imperative. This interpretative convergence begets
diagnostic precision, incites informed therapeutic dialogues, and guides
the precise planning of strategies to ensure optimal patient care and
nephrological well-being.
Liver function tests (LFT): LFT is an integral component of clinical
hepatology, encompass a series of biochemical analyses meticulously
designed to assess the multifaceted aspects of hepatic physiology. These
Preparing an Organ Recipient
165
Dr Gopi Ayyaswamy
assays stand as pivotal tools in deciphering the intricacies of liver health
and pathology. The quintessential parameters within LFTs include:
• Alanine transaminase (ALT) and aspartate transaminase (AST): These
hepatocellular enzymes, localized within the liver’s cytoplasm and
mitochondria respectively, epitomize the delicate equilibrium between
hepatic homeostasis and perturbation. Elevations in ALT and AST
activities serve as discerning markers of hepatocellular compromise,
denoting conditions ranging from mild inammation to necrosis. The
nuanced distinction between ALT, with its heightened specicity to
liver parenchyma, and AST, which may emanate from diverse tissues,
orchestrates precise diagnostic interpretations.
• Bilirubin levels: Bilirubin, a byproduct of heme catabolism, materializes
as a formidable determinant of liver function. Evaluation of bilirubin
concentration serves as a barometer for the liver’s proficiency in
bilirubin conjugation and excretion. Delineating total bilirubin into
its direct (conjugated) and indirect (unconjugated) components offers
a panoramic insight into hepatobiliary dynamics. Elevated bilirubin,
whether conjugated or unconjugated, reflect of varied etiologies
encompassing hepatocellular injury, cholestasis, or hemolysis.
The careful analysis of ALT, AST, and bilirubin measurements assists
the medical team in grasping the details of liver cell health and function.
Making sense of these results based on the patient’s situation is extremely
important, as it guides diagnosis, treatment discussions, and the careful
planning of how to care for the patient.
Thyroid Function Panel
• Evaluation of free triiodothyronine (Free T3) and free thyroxine (Free T4).
• Assessment of triiodothyronine (T3), thyroxine (T4), and thyroid-
stimulating hormone (TSH).
Serology Tests
• Hepatitis B surface antigen (HBsAg) and antibody (anti-HBs)
• Hepatitis C antibody (anti-HCV)
• Human immunodeciency virus (HIV) test
166
A Simple Introduction to Organ Transplant
Dr Gopi Ayyaswamy
• Cytomegalovirus (CMV) IgG and IgM
• Epstein-Barr virus (EBV) antibodies
Immunological Tests
• Human leukocyte antigen (HLA) typing: To assess compatibility
between the donor and recipient.
• Panel-reactive antibody (PRA) test: To determine the level of pre-existing
antibodies against potential donors.
• Extended investigations for organ transplant recipients.
• Crossmatching tests
Crossmatching tests are a critical aspect of the organ transplantation
process, ensuring compatibility between the donor organ and the recipient’s
immune system. They help prevent organ rejection and assess the risk of
immune-related complications. Two common types of crossmatching tests
are donor-specic antibody testing and ow cytometry crossmatch.
Donor-specic antibody testing: Donor-specic antibody (DSA) testing
It involves assessing the recipient’s blood serum for the presence of
antibodies directed specically against the potential donor’s antigens,
primarily human leukocyte antigens (HLAs). Here is an elaboration:
HLA matching: Human leukocyte antigens are proteins found on the
surface of cells, including those in organs. They play a crucial role in
immune system recognition. A close match between the recipient’s and
donor’s HLAs is ideal to minimize the risk of rejection.
Antibody detection: DSA testing identies any pre-existing antibodies in
the recipient’s blood that may react with the donor’s HLA antigens. If such
antibodies are present, it suggests sensitization to these antigens, which
can increase the risk of rejection.
Compatibility assessment: The results of DSA testing help transplant teams
determine the compatibility between the recipient and the potential donor.
If high levels of DSA are detected against the donor’s antigens, it may
indicate a higher risk of hyperacute or acute antibody-mediated rejection.
Preparing an Organ Recipient
167
Dr Gopi Ayyaswamy
Immunosuppressive strategies: Based on DSA results, transplant teams
can develop individualized immunosuppressive regimens to mitigate
the risk of antibody-mediated rejection. These strategies may include
plasmapheresis, intravenous immunoglobulin (IVIG) therapy, or the use
of specic immunosuppressive medications.
Monitoring: DSA testing is also crucial for monitoring transplant recipients
after the procedure. It helps identify the development of de novo antibodies
against the donor’s antigens, which may indicate ongoing immune
sensitization.
Flow cytometry crossmatch: Flow cytometry crossmatch is another
essential test that assesses compatibility between the donor and recipient.
This test involves analyzing donor and recipient lymphocytes (a type of
white blood cell) to determine if there is a reaction between them. Here
is an elaboration.
Lymphocyte isolation: Lymphocytes from both the donor and recipient
are isolated and labeled with uorescent markers. These labeled cells
are then mixed and analysed. The ow cytometry machine detects any
interaction or reaction between the donor’s and recipient’s lymphocytes.
If there is a signicant reaction, it indicates that the recipient’s immune
system recognizes the donor’s cells as foreign and may mount an immune
response against the transplanted organ.
Immediate rejection risk: A positive ow cytometry crossmatch suggests
an increased risk of hyperacute or acute antibody-mediated rejection. In
such cases, transplant teams may need to reconsider the transplantation
or implement additional strategies to reduce the risk.
Complement-dependent crossmatch: Flow cytometry crossmatch can
be further divided into complement-dependent and non-complement-
dependent crossmatches. The complement-dependent crossmatch
evaluates the recipient’s serum for the presence of antibodies that can
activate the complement system, leading to cell destruction.
Crossmatching tests, including both DSA testing and ow cytometry
crossmatch, are crucial for assessing compatibility and minimizing
the risk of rejection in organ transplant recipients. These tests allow
transplant teams to make informed decisions about organ acceptance
168
A Simple Introduction to Organ Transplant
Dr Gopi Ayyaswamy
and tailor immunosuppressive therapies to individual patient needs,
ultimately improving the success rates and long-term outcomes of organ
transplantation.
Coagulation Tests
• For organ transplant recipients, coagulation tests play a vital role in
ensuring both the safety of the transplant procedure and the post-
operative well-being of the recipient. These tests are instrumental in
assessing the patient’s blood clotting function and ensuring that the
risk of bleeding or thrombosis (clot formation) is properly managed.
Two key coagulation tests commonly performed in organ transplant
recipients are prothrombin time (PT) and international normalized ratio
(INR) and activated partial thromboplastin time (aPTT).
• Prothrombin time (PT) and international normalized ratio (INR):
These tests are used to evaluate the extrinsic clotting pathway. The PT
measures the time it takes for the blood to clot after specic clotting
factors (primarily factors I, II, V, VII, and X) are activated. It is expressed
as the PT value in seconds. The INR is a standardized measure of PT,
ensuring consistency in test results across different laboratories and
reagents. In the context of organ transplantation, PT and INR values are
essential to determine the patient’s clotting status. Abnormal PT and INR
values may indicate a deciency in clotting factors, which can increase
the risk of bleeding during or after surgery. Physicians can adjust the
patient’s clotting factor levels through medication, such as vitamin K or
specic clotting factor concentrates, to optimize their coagulation status
before transplantation.
• Activated partial thromboplastin time (aPTT): This test assesses the
intrinsic clotting pathway, focusing on factors VIII, IX, XI, and XII, among
others. It measures the time it takes for blood to clot after activating these
factors. Like PT and INR, aPTT results help gauge the patient’s clotting
ability. For organ transplant recipients, aPTT is particularly important
because it provides insights into the intrinsic clotting cascade. Abnormal
aPTT values may indicate a deciency in one or more of the intrinsic
clotting factors, potentially increasing the risk of bleeding. Physicians
can use this information to tailor treatment strategies, such as factor
replacement therapy or adjustments in anticoagulant medications, to
Preparing an Organ Recipient
169
Dr Gopi Ayyaswamy
ensure that the patient’s clotting prole is suitable for the transplant
procedure.
These coagulation tests are routinely monitored before and after
organ transplantation to ensure that the recipient’s blood is capable of
adequate clot formation. Achieving the right balance between preventing
excessive bleeding and avoiding dangerous clot formation is crucial in
these high-stakes surgical procedures. Through continuous monitoring
and appropriate adjustments, healthcare providers can optimize the
coagulation status of organ transplant recipients, thereby enhancing the
chances of a successful transplantation and minimizing the risks associated
with coagulation abnormalities.
Diagnostic Imaging Assessments
The imaging studies help transplant teams thoroughly assess the recipient’s
overall health and the condition of the organs involved in the transplant.
Here is an elaboration on the diagnostic imaging assessments commonly
performed:
• Chest X-ray: This imaging technique is employed to evaluate the
pulmonary (lung) and cardiac (heart) well-being of the organ transplant
recipient. Before transplantation, it is essential to ensure that the
recipient’s lungs and heart are in good condition, as these organs play a
vital role in oxygenating the newly transplanted organ and supporting
overall recovery. Chest X-rays can detect abnormalities in the lungs,
such as infections, tumors, or uid accumulation. Any pre-existing
lung issues need to be identied and managed to prevent complications
during and after surgery. The heart’s size, shape, and position within the
chest can be evaluated and this information helps assess the recipient’s
cardiac function and ensures that their heart is capable of handling the
physiological stresses associated with transplantation.
• Abdominal ultrasonography: This imaging modality is particularly
useful for examining the abdominal cavity and its contents. Abdominal
ultrasonography is employed to assess the architecture and vascular
dynamics of the abdominal organs, including the liver, kidneys,
spleen, and blood vessels. Ultrasonography provides detailed images
of the organs’ size, shape, and structural integrity. It can identify any
170
A Simple Introduction to Organ Transplant
Dr Gopi Ayyaswamy
tumors, cysts, or other abnormalities that may affect organ suitability
for transplantation. Ultrasonography is crucial for assessing the blood
vessels supplying and draining the abdominal organs. The patency
(openness) and integrity of these vessels are essential for successful
transplantation, as they determine the blood supply to the newly
transplanted organ.
• Computed tomography (CT) imaging of the abdomen: CT scans offer
a more comprehensive visualization of abdominal structures compared
to ultrasonography. They provide detailed cross-sectional images that
help transplant teams assess the anatomical relationships between
organs and vessels. CT imaging can detect abnormalities in the organs
with high precision. It is particularly valuable for evaluating the liver’s
size, shape, and vascular anatomy, as well as assessing the condition of
the recipient’s own organs before transplantation. In vascular mapping
CT scans can precisely map the blood vessels in the abdominal region,
ensuring that the vascular connections of the transplanted organ can
be properly established during the surgery.
• Magnetic resonance imaging (MRI) investigation: MRI may be utilized
if specic concerns or clinical indications warrant it. MRI provides
detailed images without exposing the patient to ionizing radiation. It
can offer valuable information about the organs and soft tissues, helping
the transplant team make informed decisions about transplantation
when needed.
Diagnostic imaging assessments are crucial for thoroughly evaluating
organ transplant recipients. These tests help identify any pre-existing
conditions, anatomical variations, or abnormalities that may impact the
success of the transplant procedure. By providing a comprehensive view
of the recipient’s health and organ status, these imaging studies assist
transplant teams in making well-informed decisions, optimizing the
transplantation process, and ensuring the recipient’s overall well-being.
Pulmonary Function Tests
Pulmonary function tests (PFTs) are a crucial component, especially for
those receiving lung or heart–lung transplants. These tests assess the
recipient’s lung function and capacity, providing critical information to the
Preparing an Organ Recipient
171
Dr Gopi Ayyaswamy
transplant team. Here is an elaboration on the pulmonary function tests
commonly performed. Spirometry is a primary pulmonary function test
used to assess lung function. During this test, the recipient breathes into
a device called a spirometer, which measures various lung volumes and
capacities. Key parameters measured include:
• Forced vital capacity (FVC): FVC is the maximum volume of air a person
can exhale forcefully after taking a deep breath. It reects the overall lung
capacity and the ability to exhale effectively. Forced expiratory volume
in 1 second (FEV
1
) is the volume of air forcefully exhaled during the rst
second of the FVC test. It assesses the speed and efciency of airow
and is crucial for diagnosing and monitoring lung diseases.
• FEV
1
/FVC ratio: This ratio compares the FEV
1
to the FVC and helps
diagnose the type and severity of lung diseases. A decreased ratio may
indicate obstructive lung diseases like chronic obstructive pulmonary
disease (COPD).
• Peak expiratory flow (PEF): PEF measures the maximum airflow
achieved during a forced expiration. It provides additional information
about airway function and obstruction. Spirometry helps identify any
obstructive or restrictive lung diseases that may affect the recipient’s
suitability for transplantation. It also serves as a baseline for post-
transplant lung function assessment.
• Lung volume testing: Lung volume tests provide a more detailed
assessment of lung capacity and volume. These tests can include:
• Total lung capacity (TLC): TLC measures the maximum amount of air
the lungs can hold after a deep inhalation. It evaluates the overall lung
size and helps diagnose restrictive lung diseases. Residual volume (RV):
RV measures the volume of air remaining in the lungs after a maximal
exhalation. Elevated RV values can indicate air trapping, often seen in
conditions like COPD. Functional residual capacity (FRC): FRC assesses
the volume of air in the lungs at the end of a normal exhalation. It is
crucial for understanding lung function and airway patency.
Lung volume testing provides valuable information about the
recipient’s lung compliance, which is vital for the success of lung
transplantation. It helps transplant teams select an appropriately
172
A Simple Introduction to Organ Transplant
Dr Gopi Ayyaswamy
sized donor organ and assesses the potential for post-transplant lung
expansion. Pulmonary function tests play a critical role in determining
the recipient’s suitability for organ transplantation, particularly for lung,
heart–lung, or combined heart–lung transplants. They help assess the
recipient’s baseline lung function, identify any pre-existing lung diseases,
and establish a reference point for monitoring post-transplant lung
function. This information allows transplant teams to make informed
decisions about transplantation, select suitable donor organs, and provide
appropriate post-operative care to optimize the recipient’s chances of a
successful transplant outcome.
Cardiac Assessment
• Electrocardiogram (ECG)
• Echocardiogram: To evaluate cardiac function and anatomical
characteristics.
• Exercise tolerance test (Treadmill test)
• 24-Hour Holter ECG monitoring
• 24-Hour ambulatory blood pressure monitoring
Dental and Infection Screening
• Dental examination: To identify potential oral infections that could
affect post-transplant health.
• Tuberculosis (TB) testing: To screen for latent or active TB infection.
Endoscopic Examination (If indicated)
• Esophagogastroduodenoscopy (upper gastrointestinal endoscopy)
• Ileocolonoscopy (lower gastrointestinal endoscopy)
• Colonoscopic evaluation
Vitamin and Mineral Levels
• Vitamin D: Assesses the level of vitamin D, which plays a crucial role
in maintaining bone health, immune function, and overall well-being.
Preparing an Organ Recipient
173
Dr Gopi Ayyaswamy
• Vitamin B
12
: Evaluates vitamin B
12
levels, important for nerve function,
DNA synthesis, and red blood cell production.
• Folate (vitamin B
9
): Measures the level of folate, essential for cell
division, DNA synthesis, and overall cell function.
• Iron: Checks the iron level in the blood, important for the production
of hemoglobin and prevention of anemia.
• Calcium: Assesses calcium levels, crucial for bone health, muscle
function, nerve transmission, and various cellular processes.
• Magnesium: Measures magnesium levels, necessary for muscle and
nerve function, energy production, and maintaining a healthy immune
system.
• Phosphorus: Checks the phosphorus level, important for bone health,
energy metabolism, and various cellular processes.
• Potassium: Evaluates potassium levels, essential for maintaining proper
uid and electrolyte balance, nerve function, and muscle contractions.
• Sodium: Measures sodium levels, important for maintaining proper
uid balance, nerve function, and overall cellular function.
• Zinc: Assesses zinc levels, which play a role in immune function, wound
healing, and various enzymatic reactions.
These basic vitamin and mineral levels provide important insights into
overall nutritional status and can help identify potential deciencies or
imbalances that may require further attention or supplementation. Keep
in mind that the specic vitamins and minerals tested can vary based on
individual health concerns and the healthcare provider’s recommendations.
Comprehensive Infectious Disease Panel (As Required)
• Erythrocyte sedimentation rate (ESR): A marker of inammation that
can be elevated in various infectious conditions.
• C-Reactive protein (CRP): An acute-phase protein that increases during
inammation, including infections.
• Leukocyte ratio 6 (LR6): A specialized leukocyte ratio used in the
assessment of infectious diseases.